Search company, investor...

Executives

9

Board of Directors

3

Navigenics Management Team

9 Team Members

Navigenics has 9 executives. Navigenics's current Chief Security Officer is Dietrich A Stephan.

Name

Work History

Title

Status

Dietrich A Stephan

Chief Security Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Dietrich A Stephan

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Security Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Navigenics Board of Directors

3 Board of directors

Navigenics has 3 board of directors, including David Brailer.

Name

Firm

Work History

Other Seats

David Brailer

Navigenics

L. John Doerr

L. John Doerr has served as one of our directors since March 2015. Mr. Doerr has been a General Partner of Kleiner Perkins Caufield & Byers, or KPCB, a venture capital firm, since August 1980. He currently serves on the board of directors of Alphabet Inc., the parent holding company of Google, Inc., and Amyris, Inc., a renewable products company. Mr. Doerr previously served as a director of Bloom Energy Corporation, a clean energy company, Zynga Inc., a social gaming company, QuantumScape Corporation, a renewable energy company, Coursera, an education tech company, and Amazon.com, Inc., an e-commerce company. He holds a B.S. in Electrical Engineering and an M.S. in Electrical Engineering and Computer Science from Rice University and an M.B.A. from Harvard Business School.

Navigenics

Nathan Estruth

Navigenics

Name

David Brailer

L. John Doerr

Nathan Estruth

Firm

Work History

L. John Doerr has served as one of our directors since March 2015. Mr. Doerr has been a General Partner of Kleiner Perkins Caufield & Byers, or KPCB, a venture capital firm, since August 1980. He currently serves on the board of directors of Alphabet Inc., the parent holding company of Google, Inc., and Amyris, Inc., a renewable products company. Mr. Doerr previously served as a director of Bloom Energy Corporation, a clean energy company, Zynga Inc., a social gaming company, QuantumScape Corporation, a renewable energy company, Coursera, an education tech company, and Amazon.com, Inc., an e-commerce company. He holds a B.S. in Electrical Engineering and an M.S. in Electrical Engineering and Computer Science from Rice University and an M.B.A. from Harvard Business School.

Other Seats

Navigenics

Navigenics

Navigenics

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Navigenics to Competitors

V
Viridis Diagnostics

Viridis' equipment is a disease marker testing platform to be used at point-of-care.

Life Line Screening Logo
Life Line Screening

Life Line Screening is a company focused on preventative health, operating within the healthcare sector. The company offers a range of health screening services, including cardiovascular and stroke screenings, liver, kidney, and diabetes screenings, as well as cancer and bone & joint screenings. These services are primarily aimed at individuals seeking to proactively manage their health and detect potential health risks early. It was founded in 1993 and is based in Cleveland, Ohio.

G
Genera Biosystems

Genera Biosystems specializes in advanced molecular diagnostic systems within the biotechnology sector. The company offers products and services that facilitate multiplex quantitative polymerase chain reaction (qPCR) for research and clinical applications. It is based in Australia.

X
Xeptagen S.p.A.

XEPTAGEN SpA is engaged in the discovery and validation of molecular markers in order to produce diagnostic kits for the early detection, monitoring, and screening of cancerous cells. By exploiting the natural immune response to early stage cancer and the platform technology Combinatorial Proteomic, XEPTAGEN has discovered specific tumor markers that lead to an earlier and much more accurate detection of developing carcinomas. The company's mission includes creating tools that improve the diagnostic accuracy for cancer and the clinical management of cancer patients.

A
Alerion Biomedical

Alerion Biomedical Inc. in San Diego is developing products for the detection, characterization and treatment of disease. The company is developing technologies aimed at studying and managing major diseases including cancer, vascular disorders and hepatobiliary disease. Alerion's latest product line, Fenestra, is revolutionizing the way in vivo imaging is used in basic research and drug development. Founded initially in 1997 as MetaProbe LLC by Research Corporation Technologies and the California Institute of Technology, Alerion Biomedical has grown to encompass a broad range of drug-delivery and medical imaging technologies. Advanced Research Technologies Inc., a Canadian medical device company, acquired substantially all of the imaging technology and product assets of Alerion in March 2006. ART is actively promoting the Fenestra product line.

3
3PrimiR

3PrimiR is researching how mutations in micro RNA molecules can be used in cancer diagnostics.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.